# Sai Parenterals

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/sai-parenterals
Canonical HTML page: https://getbiobrief.com/entity/sai-parenterals

## Recent coverage (1 stories)

### Sai Parenterals Debuts ₹409-Crore IPO as Pharma Injectables Gain Momentum
2026-03-24 03:08:19 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Sai Parenterals has officially opened its ₹409-crore initial public offering with a price band of ₹372–392 per share. The launch coincides with a broader surge in Indian capital markets, highlighting investor interest in specialized pharmaceutical manufacturing and sterile injectables.
Full story: https://getbiobrief.com/story/sai-parenterals-ipo-launch-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.